Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Monogenic Obesity; Using Drugs to Bypass the Problem.

Cell metabolism - 3 Jul 2018

Coll Anthony P

Abstract excerpt

Safe and effective pharmacological treatments for severe obesity remain scarce. In this issue of Cell Metabolism, Iepsen et al. (2018) show that obese patients with pathogenic melanocortin 4 receptor mutations, the most common form of monogenic obesity, lose weight with glucagon-like peptide 1 (GLP-1) receptor agonist therapy.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Body Weight
Share to Glucagon-Like Peptide-1 Receptor
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Obesity

Share to Receptor, Melanocortin, Type 4

Source

Identifiers

PMID: 29972795
DOI: 10.1016/j.cmet.2018.06.015

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Monogenic Obesity; Using Drugs to Bypass the Problem.PMID 29972795Read ↗

Current Treatments for Patients with Genetic ObesitySemantic proximity Read ↗

MECHANISMS IN ENDOCRINOLOGY: Update on treatments for patients with genetic obesity.Semantic proximity Read ↗

Rare Genetic Forms of Obesity: Clinical Approach and Current Treatments in 2016.Semantic proximity Read ↗

The promise of new anti-obesity therapies arising from knowledge of genetic obesity traits.Semantic proximity Read ↗

Rare genetic forms of obesity: From gene to therapy.Semantic proximity Read ↗

Rare genetic forms of obesity in childhood and adolescence: A narrative review of the main treatment options with a focus on innovative pharmacological therapies.Semantic proximity Read ↗

[Monogenic disorders of human obesity].Semantic proximity Read ↗

[Clinical and genetic aspects of monogenic obesity].Semantic proximity Read ↗

Melanocortin pathways: suppressed and stimulated melanocortin-4 receptor (MC4R).Semantic proximity Read ↗

Treatment of obesity: should we target the individual or society?Semantic proximity Read ↗

[Monogenetic obesity with special focus on the melanocortin 4 receptor gene mutations].Semantic proximity Read ↗

Redefining metabolically healthy obesity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.